SCOTTSDALE, ARIZONA--(Marketwire - February 05, 2008) - Holmes Biopharma, Inc. (OTCBB: HLMB) announces January sales for its Phase I operation in Omaha, Nebraska have reached 3 Million in awarded contracts. Furthermore, the Company expects to be operating the Omaha facility at full capacity through to June 2008 and anticipates this trend to continue.
